• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Progenics Pharmaceuticals

Progenics Pharmaceuticals

Progenics Pharmaceuticals Inc PGNX

Last Price$6.55Day Change (%)0.46%
Open Price$6.54Day Change ($)0.03
Day Range6.41–6.7252-Week Range3.61–8.37

As of Fri 8/26/2016 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Prostate Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Camurus, MediaPharma, Targovax - Research and Markets

    Global Prostate Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Camurus, MediaPharma, Targovax - Research and Markets

  2. Investor or Speculator?

    Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...

1
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.